Please use a PC Browser to access Register-Tadawul
Get It
Earnings Summary: Fate Therapeutics Q4
Fate Therapeutics, Inc. -4.88% Post
Fate Therapeutics, Inc. FATE | 1.17 1.21 | -4.88% +3.42% Post |
Fate Therapeutics (NASDAQ:FATE) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:00 PM.
Here's a brief overview of the earnings report.
Earnings
Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.
Revenue was down $491 thousand from the same period last year.
Overview of Past Earnings
In the previous quarter, the company beat on EPS by $0.01, resulting in a 2.85% drop change in the share price the following day.
Here's a look at Fate Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.35 | -0.46 | -0.43 |
| EPS Actual | -0.27 | -0.29 | -0.32 | -0.44 |
| Revenue Estimate | 1.35M | 947K | 1.20M | 1.57M |
| Revenue Actual | 1.74M | 1.91M | 1.63M | 1.86M |
To track all earnings releases for Fate Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
